Conducting collaborative research locally, nationally and globally.

Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 19 Next »

https://doi.org/10.1080/00952990.2024.2360984
https://doi.org/10.1111/acer.15429
https://academic.oup.com/eurpub/article/34/5/979/7637129
https://doi.org/10.1111/acps.13710
LRH.jpg
Forecasting the impact of means restriction on the suicide mortality rate in the Region of the Americas: an ecological modeling study
Shannon Lange, Kawon Kim, Huan Jiang, Kevin Shield, Jürgen Rehm, Anselm Hennis, Renato Oliveira e Souza
It was estimated that if a firearm or pesticide restriction had been implemented in 2020 in those countries where the respective means accounted for 40% or more of all suicides for at least one sex in 2019…
LRH2.jpg

https://doi.org/10.1186/s13104-024-06882-w
https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1431408
lange.jpg
elsevier.jpg A dose-response meta-analysis on the relationship between average amount of alcohol consumed and death by suicide
Shannon Lange, Laura Llamosas-Falcón, Kawon Kim, Aurélie Lasserre, Heather Orpana, Courtney Bagge, Michael Roerecke, Jürgen Rehm, Charlotte Probst
This is the first evidence synthesis on the dose-response relationship between average alcohol consumption and death by suicide.
https://doi.org/10.1186/s12913-024-11119-4

https://www.ajpmonline.org/article/S0749-3797(23)00475-0/fulltext

Int J Drug Policy.gif
elsevier.jpg Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review
Cayley Russell, Jenna Ashley, Farihah Ali, Nikki Bozinoff, Kim Corace, David Marsh, Christopher Mushquash, Jennifer Wyman, Maria Zhang, Shannon Lange
Daily supervised Opioid Agonist Treatment (OAT) medication has been identified as a barrier to treatment retention. Canadian OAT guidelines outline take-home dose (THD) criteria, yet, OAT prescribers use their clinical…
https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1291362/full
https://doi.org/10.1001/jamanetworkopen.2024.1941
https://doi.org/10.1186/s12889-024-18237-y
https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1286078
 More from Shannon Lange
  • No labels